BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20153309)

  • 1. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure.
    Christenson RH; Duh SH; Wu AH; Smith A; Abel G; deFilippi CR; Wang S; Adourian A; Adiletto C; Gardiner P
    Clin Biochem; 2010 May; 43(7-8):683-90. PubMed ID: 20153309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance characteristics of the ARCHITECT Galectin-3 assay.
    La'ulu SL; Apple FS; Murakami MM; Ler R; Roberts WL; Straseski JA
    Clin Biochem; 2013 Jan; 46(1-2):119-22. PubMed ID: 23010446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
    Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay of total inhibin: direct determination based on inhibin alpha subunit-specific monoclonal antibodies.
    Khosravi J; Krishna RG; Khaja N; Bodani U; Diamandi A
    Clin Biochem; 2004 May; 37(5):370-6. PubMed ID: 15087252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3.
    Tziakas D; Chalikias G; Parissis JT; Hatzinikolaou H; Stakos D; Papadopoulou E; Kortsaris A; Hatseras D
    Eur Cytokine Netw; 2004; 15(3):231-9. PubMed ID: 15542448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.
    Suzuki S; Takeishi Y; Niizeki T; Koyama Y; Kitahara T; Sasaki T; Sagara M; Kubota I
    Am Heart J; 2008 Jan; 155(1):75-81. PubMed ID: 18082493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy.
    Saussez S; Lorfevre F; Lequeux T; Laurent G; Chantrain G; Vertongen F; Toubeau G; Decaestecker C; Kiss R
    Oral Oncol; 2008 Jan; 44(1):86-93. PubMed ID: 17350328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices.
    Milting H; Ellinghaus P; Seewald M; Cakar H; Bohms B; Kassner A; Körfer R; Klein M; Krahn T; Kruska L; El Banayosy A; Kramer F
    J Heart Lung Transplant; 2008 Jun; 27(6):589-96. PubMed ID: 18503956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin 3 and its binding protein in rheumatoid arthritis.
    Ohshima S; Kuchen S; Seemayer CA; Kyburz D; Hirt A; Klinzing S; Michel BA; Gay RE; Liu FT; Gay S; Neidhart M
    Arthritis Rheum; 2003 Oct; 48(10):2788-95. PubMed ID: 14558084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments.
    Gaze DC; Prante C; Dreier J; Knabbe C; Collet C; Launay JM; Franekova J; Jabor A; Lennartz L; Shih J; del Rey JM; Zaninotto M; Plebani M; Collinson PO
    Clin Chem Lab Med; 2014 Jun; 52(6):919-26. PubMed ID: 24445238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients.
    Lin YH; Lin LY; Wu YW; Chien KL; Lee CM; Hsu RB; Chao CL; Wang SS; Hsein YC; Liao LC; Ho YL; Chen MF
    Clin Chim Acta; 2009 Nov; 409(1-2):96-9. PubMed ID: 19747906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3: a novel mediator of heart failure development and progression.
    de Boer RA; Voors AA; Muntendam P; van Gilst WH; van Veldhuisen DJ
    Eur J Heart Fail; 2009 Sep; 11(9):811-7. PubMed ID: 19648160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance characteristics of the Access Inhibin A assay.
    Rawlins ML; La'ulu SL; Erickson JA; Roberts WL
    Clin Chim Acta; 2008 Nov; 397(1-2):32-5. PubMed ID: 18691567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.
    Latini R; Masson S; Anand IS; Missov E; Carlson M; Vago T; Angelici L; Barlera S; Parrinello G; Maggioni AP; Tognoni G; Cohn JN;
    Circulation; 2007 Sep; 116(11):1242-9. PubMed ID: 17698733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D; Franzson L; Hoffmann JP; Isaksson A; Kaufman JM; Leary E; Müller C; Nakatsuka K; Nishizawa Y; Reinauer H; Riesen W; Roth HJ; Steinmüller T; Troch T; Bergmann P
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methodological and preanalytical evaluation of an HMGB1 immunoassay.
    Lehner J; Wittwer C; Fersching D; Siegele B; Holdenrieder S; Stoetzer OJ
    Anticancer Res; 2012 May; 32(5):2059-62. PubMed ID: 22593488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole blood interleukin-8 concentrations in capillary and cord blood of neonates for the diagnosis of systemic inflammatory states.
    Kohse KP; Carl A; Steinbach G
    Clin Lab; 2002; 48(9-10):497-503. PubMed ID: 12389710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methodological and preanalytical evaluation of a RAGE immunoassay.
    Wittwer C; Lehner J; Fersching D; Siegele B; Stoetzer OJ; Holdenrieder S
    Anticancer Res; 2012 May; 32(5):2075-8. PubMed ID: 22593491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females.
    Al-Qahtani A; Muttukrishna S; Appasamy M; Johns J; Cranfield M; Visser JA; Themmen AP; Groome NP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):267-73. PubMed ID: 16117813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.